ALDH7A1 and plasma cell myeloma: Our results presented in this study would suggest that stimulation of the cAMP signaling pathway with PDE inhibitors in conjunction with BH3-mimetics may well provide an even more effective therapeutic strategy for treatment of leukemia and multiple myeloma.